Conference Series LLC cordially invite the contributors across the globe to its premier 11th Global Summit and Expo on Vaccines, Vaccination and therapeutics, which is slated at Phoenix, USA. Sept 12-14, 2016
Sign up today and attend all three days that make up this exclusive conference successful.
Vaccines 2016 conference aims to promote and share knowledge on current research & production of vaccines. The conference gathers Immunology specialists, Scientists, Professors and research faculty from academia, Clinical, Veterinary, Medical, CEO’s, Presidents, Policy makers, Professionals from regulatory agencies, Public health professionals, Business delegates of vaccines, Value Chain community of the vaccines with the following profession areas: Innovators, Disruptors, and Influencers, Post doc and PhD students in allied disciplines across the globe under a single roof gather in Phoenix to speak on current research and future strategies for development and production of vaccines.
Vaccines 2016 gives the opportunity to hear the latest discoveries, current trends in Vaccines and Therapeutics from the global experts. The vaccines 2016 business meetings will strengthen global network with the leaders and Professionals.
Various pharmaceutical companies are developing novel vaccines for diseases such as breast cancer, lung cancer and Alzheimer, etc. Vaccines are becoming a key source for the pharmaceutical industry changing status of the vaccines within the pharma industry becoming new business model for vaccines. Newer and more expensive vaccines are coming into the market faster than ever before which leads to growing concentration in OECD countries but also newcomers.
Safety concerns associated with some vaccines like Pertussis Suggested as cause of severe neurological conditions, including permanent brain damage. The risk too small to be quantified, Polio Vaccine associated poliomyelitis, The risk estimated at 1-2 cases per million doses of vaccine and MMR Measles component may cause feverish convulsions in 1:1000 children ratio. Diphtheria Neurological reactions have been reported but the risk is too small to quantify. In general BCG vaccine severe reactions occur at injection site which is usually associated with faulty vaccination technique, however overall estimated risk is less than 1 in 200,000 vaccinations.